Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-002958

Chief Operating Officer acquired 84,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barton Russell Chief Operating Officer 2026-01-16 Grant or award +84,600 207,869 D
Derivatives
Barton Russell Chief Operating Officer 2026-01-16 Grant or award · Employee Stock Option (right to buy) +126,900 126,900 D
Loading xslF345X05/wk-form4_1769038220.xml…